KPV is the tripeptide Lys-Pro-Val, the C-terminal sequence of -MSH, investigated in cell models for anti-inflammatory activity, partly via NF-B signalling [6]
Though early, these findings point to a potential role for astaxanthin in supporting restorative sleep, especially in people experiencing fatigue or stress-related sleep disruption
Peptides with pharmacological activity invariably require registration rather than listing
Don't rush to replace the copper peptides with another active
NPI verified, no consumer access
The risk is that a clinically valuable therapy gets translated into a consumer-driven workplace perk without strong criteria around eligibility, persistence, comorbidities, monitoring, and total cost impact